Skip to main content
logo
Molecular Partners AG (LON:0QXX)
London flag London · Delayed Price · Currency is GBP · Price in CHF
3.508
-0.055 (-1.54%)
Feb 10, 2026, 10:32 AM GMT

Molecular Partners AG Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
-4.977.04189.569.339.34
Other Revenue
---0.040.42-
Revenue
-4.977.04189.69.759.34
Revenue Growth (YoY)
--29.38%-96.29%1843.82%4.39%-54.16%
Cost of Revenue
40.447.547.8449.954.9656.08
Gross Profit
-40.4-42.53-40.81139.71-45.21-46.73
Selling, General & Admin
17.1618.6820.323.0918.2111.6
Operating Expenses
17.1618.6820.323.0918.2111.6
Operating Income
-57.56-61.22-61.11116.61-63.42-58.33
Interest Expense
-0.02-0.03-0.03-0.61-0.55-0.3
Interest & Investment Income
1.943.384.281.140.10.37
Currency Exchange Gain (Loss)
-1.853.83-5.110.720.09-4.51
Other Non Operating Income (Expenses)
-0.01-0.01-0.02-0.01-0.01-0.01
Pretax Income
-60.23-54.04-61.98117.85-63.78-62.78
Income Tax Expense
-0--0-0.01
Net Income
-60.23-54.04-61.98117.85-63.79-62.76
Net Income to Common
-60.23-54.04-61.98117.85-63.79-62.76
Shares Outstanding (Basic)
373433323125
Shares Outstanding (Diluted)
373433333125
Shares Change (YoY)
12.46%3.85%-1.49%7.29%24.02%16.75%
EPS (Basic)
-1.62-1.59-1.893.63-2.06-2.51
EPS (Diluted)
-1.62-1.59-1.893.54-2.06-2.51
Free Cash Flow
-54.01-59.95-59.58117.39-91.89-30.43
Free Cash Flow Per Share
-1.45-1.76-1.823.53-2.96-1.22
Gross Margin
---73.68%--
Operating Margin
--1231.73%-868.26%61.50%-650.17%-624.21%
Profit Margin
--1087.38%-880.71%62.16%-653.94%-671.70%
Free Cash Flow Margin
--1206.30%-846.55%61.91%-942.03%-325.71%
EBITDA
-56.74-60.23-60.18119-60.85-55.44
EBITDA Margin
---62.76%--
D&A For EBITDA
0.820.990.932.392.572.89
EBIT
-57.56-61.22-61.11116.61-63.42-58.33
EBIT Margin
---61.50%--
Revenue as Reported
-4.977.04189.69.759.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.